Nonmuscle invasive bladder cancer: a primer on immunotherapy
Intravesical Bacillus Calmette-Guérin (BCG) has long been the gold standard treatment of nonmuscle invasive bladder cancer. Recently, there has been an emergence of novel immunotherapeutic agents, which have shown promise in the treatment of urothelial cell carcinoma. These agents aim to augmen...
Gorde:
| Egile Nagusiak: | , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
China Anti-Cancer Association
2016-06-01
|
| Saila: | Cancer Biology & Medicine |
| Gaiak: | |
| Sarrera elektronikoa: | http://www.cancerbiomed.org/index.php/cocr/article/view/925 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|